
    
      As a treatment for type 2 diabetesGlucagon like peptide -1 (Glucan-like peptide-1, GLP-1)
      receptor agonists plays the role of promoting insulin secretion, inhibiting glucagon
      secretionï¼Œand also has the central and peripheral effects,it can inhibit appetite,reduce
      weight.GLP-1 receptor agonists promote fat redistribution in obese women with type 2
      diabetes, reduce liver fat content, improve the inflammation state
    
  